Adagene Inc.
ADAG- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001818838
In the last 90 days, Adagene Inc. insiders filed 4 open-market purchases and 0 sales; 35 institutions reported holding it in 13F filings for Q2 2026, worth $81.0M in total; no superinvestor holds it.
Holders of 5% or more of ADAG
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Adagene Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Luo Peter | 13D/A | 11.20%9.39M shares | −4.38 ppfrom 15.58% | Feb 9, 20226 filings | Jun 8, 2026 | SEC |
| Janus Henderson Group PLC | 13G | 10.10%6.67M shares | New | May 7, 20261 filing | May 7, 2026 | SEC |
| Smith Vincent C | 13G/A | 8.70%5.10M shares | +1.80 ppfrom 6.90% | Feb 4, 20252 filings | Jan 29, 2026 | SEC |
| OT Healthcare Fund I, LLC | 13G/A | 8.10%3.57M shares | +2.20 ppfrom 5.90% | Sep 24, 20242 filings | Feb 3, 2025 | SEC |
| Chernett Jorey | 13G | 5.10%2.39M shares | New | Mar 18, 20261 filing | Mar 18, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
33 Schedule 13D and 13G filings on Adagene Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Aug 14, 20264:57 PM ET | WuXi PharmaTech Healthcare Fund I L.P.and 1 other | 13G/A | 3.50%2.89M shares | −2.40 ppfrom 5.90%Below 5% | Jun 30, 2026 | SEC |
| Jun 8, 20266:23 AM ET | Luo Peterand 1 other | 13D/A | 11.20%9.39M shares | −4.38 ppfrom 15.58% | Jun 5, 2026 | SEC |
| May 15, 20264:26 PM ET | WuXi PharmaTech Healthcare Fund I L.P.and 1 other | 13G/A | 5.90%3.49M shares | −1.10 ppfrom 7.00% | Mar 31, 2026 | SEC |
| May 7, 202611:29 AM ET | Janus Henderson Group PLC | 13G | 10.10%6.67M shares | New | Apr 30, 2026 | SEC |
| Mar 18, 20269:22 AM ET | Chernett Jorey | 13G | 5.10%2.39M shares | New | Mar 16, 2026 | SEC |
| Feb 17, 20264:30 PM ET | General Atlantic LLCand 14 others | 13G/A | 0.00%0 shares | –Below 5% | Dec 31, 2025 | SEC |
| Jan 29, 20264:16 PM ET | Smith Vincent Cand 2 others | 13G/A | 8.70%5.10M shares | +1.80 ppfrom 6.90% | Dec 31, 2025 | SEC |
| Nov 14, 20255:42 PM ET | WuXi PharmaTech Healthcare Fund I L.P.and 1 other | 13G/A | 7.00%4.12M shares | −1.50 ppfrom 8.50% | Sep 30, 2025 | SEC |
| Nov 14, 20254:30 PM ET | Panacea Innovation Ltdand 3 others | 13G/A | 3.80%2.25M shares | −1.70 ppfrom 5.50%Below 5% | Sep 30, 2025 | SEC |
| Jul 2, 20251:53 PM ET | FMR LLCand 1 other | 13G/A | 0.90%473.9K shares | –Below 5% | Jun 30, 2025 | SEC |
| May 15, 20255:29 PM ET | WuXi PharmaTech Healthcare Fund I L.P.and 1 other | 13G/A | 8.50%4.98M shares | – | Mar 31, 2025 | SEC |
| May 12, 202510:02 AM ET | FIL Ltdand 2 others | 13G/A | 1.80%936.8K shares | −6.00 ppfrom 7.80%Below 5% | Mar 31, 2025 | SEC |
| Feb 19, 20256:31 AM ET | Luo Peterand 1 other | 13D/A | 15.58%9.18M shares | – | Jan 25, 2025 | SEC |
| Feb 14, 20254:30 PM ET | Panacea Innovation Ltdand 3 others | 13G/A | 5.50%3.04M shares | – | Dec 31, 2024 | SEC |
| Feb 12, 20258:57 AM ET | FIL Ltdand 2 others | 13G/A | 7.80%4.09M shares | – | Dec 31, 2024 | SEC |
| Feb 4, 202512:26 PM ET | Smith Vincent Cand 2 others | 13G | 6.90%3.83M shares | New | Dec 31, 2024 | SEC |
| Feb 3, 20252:35 PM ET | OT Healthcare Fund I, LLCand 2 others | 13G/A | 8.10%3.57M shares | +2.20 ppfrom 5.90% | Sep 6, 2024 | SEC |
| Nov 7, 2024 | Huang James | 13G/AOld format | – | – | – | SEC |
| Sep 24, 202410:26 AM ET | OT Healthcare Fund I, LLC | 13G | 5.90%3.28M shares | New | Sep 6, 2024 | SEC |
| Mar 1, 2024 | Luo Peter | 13D/AOld format | – | – | – | SEC |
| Feb 9, 2024 | FMR LLC | 13G/AOld format | – | – | – | SEC |
| Jan 19, 2024 | Huang James | 13GOld format | – | New | – | SEC |
| Feb 17, 2023 | Luo Peter | 13D/AOld format | – | – | – | SEC |
| Feb 9, 2023 | FMR LLC | 13G/AOld format | – | – | – | SEC |
| Feb 6, 2023 | JSR Ltd | 13G/AOld format | – | – | – | SEC |
| Apr 29, 2022 | Luo Peter | 13DOld format | – | – | – | SEC |
| Feb 11, 2022 | General Atlantic LLC | 13GOld format | – | New | – | SEC |
| Feb 9, 2022 | Luo Peter | 13GOld format | – | New | – | SEC |
| Feb 9, 2022 | FMR LLC | 13G/AOld format | – | – | – | SEC |
| Jan 26, 2022 | WuXi PharmaTech Healthcare Fund I L.P. | 13GOld format | – | New | – | SEC |
| Jan 26, 2022 | JSR Ltd | 13GOld format | – | New | – | SEC |
| Feb 19, 2021 | FIL Ltd | 13GOld format | – | New | – | SEC |
| Feb 19, 2021 | FMR LLC | 13GOld format | – | New | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Adagene Inc. shares.
No Form 144 notices for Adagene Inc. are on file.